BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 381076)

  • 1. Potency and suppurative adenitis in BCG vaccination.
    Gheorghiu M; Carnus H; Lagrange P; Chambon L
    Dev Biol Stand; 1978; 41():79-84. PubMed ID: 381076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
    De Britto RL; Ramanathan VD; Gupte MD
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the number of viable units in BCG vaccines.
    Nyerges G; Drinóczy M
    Dev Biol Stand; 1986; 58 ( Pt A)():331-6. PubMed ID: 3297870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
    Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
    Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
    Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG)].
    Cerdá de Palou E; de Santy HP
    Ned Tijdschr Geneeskd; 2003 Mar; 147(12):569-72. PubMed ID: 12693089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Caseation of lymph nodes in infants after intracutaneous vaccination with original French BCG vaccine].
    Zapaśnik-Kobierska MH; Buraczewska M; Rajtar-Leontiew Z
    Pediatr Pol; 1970 Aug; 45(8):923-8. PubMed ID: 4918878
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycobacterium bovis lymphadenitis complicating BCG immunization in an infant with symptomatic HIV-1 infection.
    Marks K; Amitai Y; Engelhard D; Kori M; Maayan S
    Isr J Med Sci; 1993; 29(6-7):381-2. PubMed ID: 8349456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of the effectiveness of vaccination of newborn infants with BCG and BCG-M vaccines].
    Mitinskaia LA; Demeshko ND; Efimova AA; Litseva OA; Iablokova TB; Levi DT; Pisarenko NN; Kogan ES
    Probl Tuberk; 1990; (12):3-5. PubMed ID: 2084688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse events following BCG vaccination].
    Sagić L
    Med Pregl; 2004; 57 Suppl 1():41-7. PubMed ID: 15686221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "BCG"-vaccine studies suppurative lymphadenitis following intradermal B.C.G. vaccination of the newborn.
    Fahim S; el-Alamy M; Asaad F
    J Egypt Public Health Assoc; 1972; 47(2):106-13. PubMed ID: 4558336
    [No Abstract]   [Full Text] [Related]  

  • 12. [Regional adenitis following BCG vaccination (author's transl)].
    García Mérida M; Miguélez Lago C; Argos Rodríguez D; Bentabol Moreno G; López Pérez GA
    An Esp Pediatr; 1979; 12(8-9):597-602. PubMed ID: 496095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe axillary lymphadenitis after BCG vaccination: alert for primary immunodeficiencies.
    Santos A; Dias A; Cordeiro A; Cordinhã C; Lemos S; Rocha G; Faria E
    J Microbiol Immunol Infect; 2010 Dec; 43(6):530-7. PubMed ID: 21195982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of Bacille Calmette-Guérin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine.
    Alrabiaah AA; Alsubaie SS; Bukhari EI; Gad A; Alzamel FA
    Ann Saudi Med; 2012; 32(1):4-8. PubMed ID: 22156633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cervical adenitis due to BCG. Problem of vaccination by oral route].
    Blancher G; Cohen F; Corbin R; Falconnier J
    Bull Mem Soc Med Hop Paris; 1968; 119(13):1003-8. PubMed ID: 5729342
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children.
    Al-Hajoj S; Memish Z; Abuljadayel N; AlHakeem R; AlRabiah F; Varghese B
    PLoS One; 2014; 9(11):e113472. PubMed ID: 25409184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG vaccination of neonates, infants, schoolchildren and adolescents. Part II: Safety of a vaccine with strain 1331 Copenhagen.
    Lehmann HG; Engelhardt H; Freudenstein H; Hennessen W; Quast U; Widmark RM
    Dev Biol Stand; 1979; 43():133-6. PubMed ID: 520665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse event after BCG vaccination in Poland in the years 1994-1997].
    Szczuka I
    Pneumonol Alergol Pol; 1999; 67(5-6):208-16. PubMed ID: 10570642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.